Are you an EPFL student looking for a semester project?
Work with us on data science and visualisation projects, and deploy your project as an app on top of Graph Search.
Concept
Vijay S. Pande
Summary
Vijay Satyanand Pande is a Trinidadian–American scientist and venture capitalist. Pande is the former director of the biophysics program and is best known for orchestrating the distributed computing disease research project known as Folding@home. His research is focused on distributed computing and computer-modelling of microbiology and on improving computer simulations regarding drug-binding, protein design, and synthetic bio-mimetic polymers. Pande became the ninth general partner at venture capital firm Andreessen Horowitz in November 2015. He is the founding investor of their Bio + Health Fund.
Pande is an adjunct professor of bioengineering at Stanford University. Previously, he was the Henry Dreyfus Professor of Chemistry and professor of structural biology and of computer science. He was also director of the biophysics program.
Pande serves on the boards of Apeel Sciences, Bayesian Health, BioAge Labs, Citizen, Devoted Health, Freenome, Insitro, Nautilus Biotechnology, Nobell, Omada Health, Q.bio, and Scribe Therapeutics, a CRISPR company co-founded by 2020 Nobel Laureate Jennifer Doudna. He has also been a founder and advisor to startups in Silicon Valley.
Pande has written for TIME, STAT News, Fortune, and the New York Times, among others.
In 2014, Pande co-founded Globavir Biosciences, an infectious disease startup addressing antibiotic resistance threats in developed countries as well as needs in viral infections around the world, including Ebola and dengue fever.
Pande founded the Pande Lab at Stanford University. The lab brings together researchers from many departments, including Chemistry, Computer Science, Structural Biology, Physics, Biophysics, and Biochemistry.
Pande is the founder of the Folding@home research project.
The protein-folding computer simulations from the Folding@home project is said to be "quantitatively" comparable to real-world experimental results. The method for this yield has been called a "holy grail" in computational biology.
Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.